Chargement en cours...
MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer
There is mounting evidence that cancer stem-like cells (CSCs) are selectively enriched in residual tumors after anticancer therapies which may account for tumor recurrence and metastasis by regenerating new tumors. Thus, there is a critical need to develop new therapeutic agents that can effectively...
Enregistré dans:
| Publié dans: | Cancer Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5712265/ https://ncbi.nlm.nih.gov/pubmed/28951456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-3452 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|